Your browser doesn't support javascript.
loading
The Oncology Biomarker Discovery framework reveals cetuximab and bevacizumab response patterns in metastatic colorectal cancer.
Ohnmacht, Alexander J; Stahler, Arndt; Stintzing, Sebastian; Modest, Dominik P; Holch, Julian W; Westphalen, C Benedikt; Hölzel, Linus; Schübel, Marisa K; Galhoz, Ana; Farnoud, Ali; Ud-Dean, Minhaz; Vehling-Kaiser, Ursula; Decker, Thomas; Moehler, Markus; Heinig, Matthias; Heinemann, Volker; Menden, Michael P.
Afiliação
  • Ohnmacht AJ; Computational Health Center, Helmholtz Munich, 85764, Neuherberg, Germany.
  • Stahler A; Department of Biology, Ludwig-Maximilians University Munich, 82152, Martinsried, Germany.
  • Stintzing S; Charité Universitätsmedizin, corporate member of Freie Universität Berlin and Humboldt-Universität zu Berlin, Department of Hematology, Oncology, and Cancer Immunology, Charitéplatz 1, 10117, Berlin, Germany.
  • Modest DP; Charité Universitätsmedizin, corporate member of Freie Universität Berlin and Humboldt-Universität zu Berlin, Department of Hematology, Oncology, and Cancer Immunology, Charitéplatz 1, 10117, Berlin, Germany.
  • Holch JW; German Cancer Consortium (DKTK), partner sites Berlin and Munich, German Cancer Research Center (DKFZ), 69120, Heidelberg, Germany.
  • Westphalen CB; Charité Universitätsmedizin, corporate member of Freie Universität Berlin and Humboldt-Universität zu Berlin, Department of Hematology, Oncology, and Cancer Immunology, Charitéplatz 1, 10117, Berlin, Germany.
  • Hölzel L; German Cancer Consortium (DKTK), partner sites Berlin and Munich, German Cancer Research Center (DKFZ), 69120, Heidelberg, Germany.
  • Schübel MK; Department of Medicine III and Comprehensive Cancer Center Munich, University Hospital, Ludwig-Maximilians University Munich, 81377, Munich, Germany.
  • Galhoz A; Department of Medicine III and Comprehensive Cancer Center Munich, University Hospital, Ludwig-Maximilians University Munich, 81377, Munich, Germany.
  • Farnoud A; Computational Health Center, Helmholtz Munich, 85764, Neuherberg, Germany.
  • Ud-Dean M; Computational Health Center, Helmholtz Munich, 85764, Neuherberg, Germany.
  • Vehling-Kaiser U; Department of Biology, Ludwig-Maximilians University Munich, 82152, Martinsried, Germany.
  • Decker T; Computational Health Center, Helmholtz Munich, 85764, Neuherberg, Germany.
  • Moehler M; Department of Biology, Ludwig-Maximilians University Munich, 82152, Martinsried, Germany.
  • Heinig M; Computational Health Center, Helmholtz Munich, 85764, Neuherberg, Germany.
  • Heinemann V; Computational Health Center, Helmholtz Munich, 85764, Neuherberg, Germany.
  • Menden MP; Oncological Practice, 84028, Landshut, Germany.
Nat Commun ; 14(1): 5391, 2023 09 04.
Article em En | MEDLINE | ID: mdl-37666855
Assuntos
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Neoplasias Retais / Neoplasias Colorretais / Neoplasias do Colo Tipo de estudo: Clinical_trials Limite: Humans Idioma: En Ano de publicação: 2023 Tipo de documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Neoplasias Retais / Neoplasias Colorretais / Neoplasias do Colo Tipo de estudo: Clinical_trials Limite: Humans Idioma: En Ano de publicação: 2023 Tipo de documento: Article